Letybo

Letybo is an injectable neurotoxin used to soften frown lines between the eyebrows by temporarily relaxing the muscles responsible. It works by blocking acetylcholine release at the neuromuscular junction, reducing muscle contractions and smoothing wrinkles.

Molecule Details :

  • Molecule Name :

    Letibotulinumtoxina-Wlbg
  • Innovator :

    HUGEL, INC.
  • Approval Date :

    29-Feb-24
  • Data Exclusivity Expiry :

    29-Feb-28
  • Market Exclusivity Expiry :

    29-Feb-36
  • Dosage Form :

    IM Injection
  • Strength :

    50 units per vial and 100 units per vial
  • Therapeutic Category :

    Dermatologic
  • Revenue ($M) :

    NA

Year-wise Projected Sales ($M) :

  • 2025 :

    NA
  • 2026 :

    NA
  • 2027 :

    NA
  • 2028 :

    NA
  • 2029 :

    NA
  • 2030 :

    NA
  • 2031 :

    NA
Looking for this molecule for your next clinical research? Access regulatory-compliant comparators with assured timelines—delivered reliably through our global network.

Why Choose Spring Bio Solution?

Supported 1000+ Clinical Trials globally

Provides services across regulatory, legal & clinical research

Unmatched intelligence on batches, expiry, spacing, and historical data from innovators

Integrated CRO Services as part of our offerings

Insights on global pricing for smarter clinical trial supply decisions 


Login NCE Grid

Register NCE Grid

Are you sure want to logout from NCE Grid?